Revive Therapeutics (OTC:RVVTF) said today it inked a collaborative research deal with Sanyal Biotechnology looking to explore the use of cannabinoids as potential treatments for liver diseases. The collaborative deal will initially focus on the use of cannabidiol on a novel autoimmune hepatitis model, using the Diamond model which was designed and developed by Sanyal Biotechnologyspecifically […]
